ABOUT THE JOURNAL

• Aims and scope of journal |
• Abstracted/indexed in |
• ISSN and eISSN |
• Editors |

Aims and scope of journal

Under the guidance of a highly respected Editor and an expert Editorial Board each quarterly issue publishes analyses, briefings and updates which are of direct relevance to practitioners and that meet the highest intellectual standards.

Subscribing to Journal of Generic Medicines will give you and your organization access to the latest thinking from some of the world's leading authorities, including articles on:

• strategies for challenging and protecting patents
• pricing and reimbursement trends and policies - country by country
• fair and unfair tactics to block generic competition
• patent expiries and their impact on national, regional and global markets
• business development strategies and licensing agreements
• clinical trials and bioequivalence studies
• m&a strategy
• regulatory affairs
• major buyers' tender procedures
• data exclusivity and patents
• manufacturing and outsourcing
• briefings from government agencies
• marketing and branding strategies
• strategies for challenging innovators
• analysis of disease sectors
• own brand markets
• R&D
• legal briefings - including case law discussions
• market reviews
• the OTC generic market
• packaging and labelling
• biogenerics
• purchase strategies

Abstracted/indexed in

• EMBASE
• SCOPUS

ISSN and eISSN

The international standard serial number (ISSN) for Journal of Generic Medicines is 1741-1343 and the electronic international standard serial number (eISSN) is 1741-7090.

Editors

Managing Editor

M. Fabiana Jorge, President, MFJ International, LLC, USA
E-mail: mfjorge@mfjint.com

Consulting Editor

Greg Perry, Director General, European Generic Medicines Association, Belgium

Association/Regional Advisors

Africa: NAPM Chairman Skhumbuzo Ngozwana
Australasia: GMiA CEO Kate Lymch
Canada: CGPA President Jim Keon
Europe: EGA Director of Pharmaceutical Policy Elke Grooten
India and Asia (exc Japan): IPA Secretary General Dilip G. Shah
Japan: IGPA Committee of JGPMA, Vice chairman Juichi Riku
Latin America: MFJ International LLC Senior Director Dolores Cullen
USA: GPhA President and CEO Kathleen Jaeger

Editorial Board

C. Anthony Butler, Barclays Capital, USA
Nicholas F. Cappucccino, General Partner, Pharmaceutical Intellectual Resource Services LLC, USA
Carlos Correa, Director of the Center for Interdisciplinary Studies on Industrial Property Law and Economics, CEIDIE, Argentina
Richard DiCicco, Prresident, Technology Catalysts International, USA
Graham Dukes, Professor of Drug Policy Studies, University of Oslo, Norway
Richard Eggleston, Director of Research and Development and Technical Affairs, PERRIGO, UK
Eric B. Fastiff, Partner, Lieff, Cabraser, Heimann & Bernstein, LLP, USA
Nicholas M. Fleischer, Vice-President, Clinical Pharmacology and Biopharmaceutics, The Weinberg Group Inc., USA
Torsten Goesch, BioSciences Managers Ltd, Germany
William F. Haddad, Chairman/CEO, Biogenerics, Inc, USA
Jean Hoffman, President, Putney, Inc, USA
Juhana Idänpään-Heikkilä, Senior Adviser, CIOMS c/o World Health Organization, Switzerland
Gordon Johnston, Vice President of Regulatory Affairs, Generic Pharmaceutical Industry Association, USA
Rossen Kazakov, Executive Director, BGPharmA, Bulgaria
Yehudah Livneh, General Patent Counsel, Teva Pharmaceutical Industries Limited, Israel
Jean-Michel Peny, President, Smart Pharma Consulting, France
Rebecca Robins, Global Marketing Director, Interbrand Healthcare, UK
Paolo Romagnoli, Director of Pharmaceutical, Chemicals, Recordati SpA, Italy
Richard Silver, Barclays Capital, USA
Steven Simoens, Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, Belgium
Warwick Smith, Director, British Generic Manufacturers Association, UK
Ambrose Stafford, Vice President, Apicore LLC, USA
Brian Tempest, Chairman, Hale & Tempest Co Ltd., UK
Bozidar Vrhovac, Medical School University of Zagreb, Croatia
Lawrence Yu, Director for Science, Office of Generic Drugs, Food and Drug Administration and adjunct Professor of Pharmaceutical Engineering, University of Michigan, USA

US Legal Update Editor

Neil Greenblum, Co-managing partner, Greenblum & Bernstein PLC, USA

EU Legal Update Editor

Richard Milchior, SCP Granrut Avocats, France

Editor of Patent Focus Regular Feature

Leighton Howard, GenericsWeb, UK

EU Case Reports Editor

Michael Burdon, Partner, Head of Biosciences Group, Olswang, UK

US Case Reports Editor

Frederick H. Rein, Partner, Goodwin Procter LLP, USA

Editorial Office

• Neil Henderson
  Publishing Manager
  Palgrave Macmillan
  Houndmills
  Basingstoke RG21 6XS, UK
  E-mail: n.henderson@palgrave.com
  Please clearly state for which journal you are contributing.